(MedPage Today) — Finerenone (Kerendia) slowed the decline of kidney function in adults with chronic kidney disease (CKD) who did not have diabetes, the large randomized FIND-CKD trial showed.
By month 32, the mean annual rate of change in estimated…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
